Kelly E. Dunn, PhD, MBA
- Academic Title: Professor
- Primary Appointment: Psychiatry
- Administrative Title: Director of the Kahlert Institute for Addiction Medicine
- Additional Title: Professor of Psychiatry and Neurobiology
- Email: kelly.dunn@som.umaryland.edu
Education and Training
- 2002, BA, Psychology, Oswego State University
- 2002, BA, Philosophy, Oswego State University
- 2005, MS, Applied Biopsychology, University of New Orleans
- 2009, PhD, Human Behavioral Pharmacology/Experimental Psychology, University of Vermont
- 2011, Postdoctoral Training, Johns Hopkins University School of Medicine
- 2019, MBA, Healthcare Management, Johns Hopkins Carey School of Business
Biosketch
Kelly Dunn, PhD, has been working in the field of opioid use disorder (OUD) since 2005. As a teenager growing up in rural Central New York in the late 1990s, Dr. Dunn watched several close friends be introduced to opioid use through prescription medications. Many of these friends became dependent on opioids used nonmedically and eventually developed OUD. This experience prompted Dr. Dunn's lifelong passion for understanding motivations for opioid use, identifying methods to prevent the onset of OUD, helping to improve treatments for OUD and exploring new methods for managing pain and reducing opioid reliance.
Dr. Dunn has now been the principal investigator on projects totaling more than $20 million in awards from the National Institutes of Health and is an author on more than 150 peer-reviewed publications in the area of substance use and OUD. She is the editor of the Oxford Handbook for Opioid Use and Opioid Use Disorder. She has held several leadership positions in the field of substance use, including president of the College on the Problems of Drug Dependence and Society for Psychopharmacology and Substance Use, editor of the journal Experimental and Clinical Psychopharmacology and co-editor of the Journal of Addiction Medicine. She also served as chair of program committees for the College on the Problems of Drug Dependence and the American Psychological Association. She is available and open to consult with companies seeking to develop new medications for the treatment of OUD and persons working to help advance the field of addiction science and medicine.
Research/Clinical Keywords
Addiction, Buprenorphine, Medication, Methadone, Opioids, Opioid use disorder, Psychopharmacology, Substance use disorder, Treatment, Kahlert Institute for Addiction Medicine, University of Maryland
Highlighted Publications
Additional Publications
Awards and Affiliations
- Young Psychopharmacologist Award, Division 28 of the American Psychological Association
- Joseph Cochin Young Investigator Award, College on the Problems of Drug Dependence
- Fellow, American Psychological Association